Pharmacological therapies and drug development targeting SARS-CoV-2 infection

The development of therapies for SARS-CoV-2 infection, based on virus biology and pathology, and of large- and small-scale randomized controlled trials, have brought forward several antiviral and immunomodulatory drugs targeting the disease severity. Casirivimab/Imdevimab monoclonal antibodies and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yizhou, Rubin, Limor, Zhou, Zhiwei, Zhang, Haibo, Su, Qiaozhu, Hou, Sheng-Tao, Lazarovici, Philip, Zheng, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558743/
https://www.ncbi.nlm.nih.gov/pubmed/36266222
http://dx.doi.org/10.1016/j.cytogfr.2022.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558743/
https://www.ncbi.nlm.nih.gov/pubmed/36266222
http://dx.doi.org/10.1016/j.cytogfr.2022.10.003

Ejemplares similares